Pseudoprogression of Malignant Peripheral Nerve Sheath Tumor in Patient with Neurofibromatosis Type 1, a Case Report by Andrés J. Lessing, Gregory M. Cote, Thomas F. DeLaney, Scott R. Plotkin, Kevin A. Raskin, Juan N. Lessing

Get full text

Phase 1 trial of preoperative image guided intensity modulated proton radiation therapy with simultaneously integrated boost to the high risk margin for retroperitoneal sarcomas by Thomas F. DeLaney, MD, Yen-Lin Chen, MD, Elizabeth H. Baldini, MD MPH, Dian Wang, MD PhD, Judith Adams, CMD, Shea B. Hickey, BA, Beow Y. Yeap, ScD, Stephen M. Hahn, MD, Karen De Amorim Bernstein, MD, G. Petur Nielsen, MD, Edwin Choy, MD PhD, John T. Mullen, MD, Sam S. Yoon, MD

Get full text

The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance Denial by Mike Hernandez, MS, J. Jack Lee, PhD, Beow Y. Yeap, ScD, Rong Ye, MS, Robert L. Foote, MD, Paul Busse, MD, PhD, Samir H. Patel, MD, Roi Dagan, MD, James Snider, MD, Nasiruddin Mohammed, MD, MBA, Alexander Lin, MD, Pierre Blanchard, MD, PhD, Scott B. Cantor, PhD, Menna Y. Teferra, MS, Kate Hutcheson, PhD, Pablo Yepes, PhD, Radhe Mohan, PhD, Zhongxing Liao, MD, Thomas F. DeLaney, MD, Steven J. Frank, MD

Get full text